Table 7.
Group (n = 8) | TG | TC | HDL-C | LDL-C | MDA |
---|---|---|---|---|---|
CG | 0.84 ± 0.16 b,c,d,f | 2.55 ± 0.49 b,f | 1.36 ± 0.28 b,c,d,f | 1.13 ± 0.48 b,c,d,e,f | 0.48 ± 0.17 b,d,f |
MG | 1.76 ± 0.42 a,c,d,e,f | 3.34 ± 1.50 a,c,d,e,f | 0.67 ± 0.48 a,c,e,f | 1.84 ± 0.66 a,c,e,f | 1.45 ± 0.44 a,c,d,e,f |
PIG | 2.38 ± 0.32 a,b,c,d,e,f | 3.64 ± 1.29 a,b,c,d, e,f | 0.56 ± 0.29 a,b,c,e,f | 2.09 ± 0.43 a,b,c,e,f | 1.64 ± 0.37 a,b,c,d,e,f |
BG | 1.19 ± 0.15 a,b,d,e,f | 3.26 ± 0.74 b,d,f | 1.12 ± 0.29 a,b,d | 1.52 ± 0.68 a,b,d,e, | 0.56 ± 0.39 b,d,f |
BPIG | 2.03 ± 0.65 a,b,c,e,f | 3.47 ± 0.53 a,c,e,f | 0.76 ± 0.25 a,c,e,f | 1.73 ± 0.28 a,c,e | 1.12 ± 0.36 a,b,c,e,f |
BPG | 0.92 ± 0.31 a,b,c,d,f | 3.12 ± 0.46 b,d,f | 1.24 ± 0.30 b,d,f | 1.36 ± 0.59 a,b,c,d,f | 0.41 ± 0.28 b,a,d,f |
BPPIG | 1.26 ± 0.18 a,b,c,d,e | 3.52 ± 0.68 a,b,c,d,e | 0.98 ± 0.27 a,b,c,d,e | 1.66 ± 0.49 a,b,e | 0.72 ± 0.38 a,b,c,d,e |
Note: Eight blood samples were analyzed in each group. All data are presented as mean value ± S.D. a p < 0.05 vs. the control group (CG); b p < 0.05 vs. the model group (MG); c p < 0.01 vs. the BG group; d p < 0.05 vs. BPIG (Blueberry juice and the treatment of PPAR-α inhibitor); e p < 0.05 vs. the BPG (Blueberry juice and probiotics); f p < 0.05 vs. the BPPIG group (Blueberry juice and probiotics and the treatment of PPAR-α inhibitor).